Cogent Biosciences, Inc. (COGT) Investor Relations Documents

Cogent Biosciences, Inc. (COGT) investor relations documents from the company's IR site: 4 presentations, 21 press releases; latest deck 2026-05-12. Read in-app with summaries. First-party data.

May 2026 Corporate Presentation: Cogent Biosciences' May 2026 corporate presentation highlights positive pivotal trial results for bezuclastinib in GIST and systemic mastocytosis.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-10Press releaseCogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
2026-06-30Press releaseCogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosi
2026-06-12Press releaseJune 12, 2026 Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematol
2026-06-12Press releaseJune 12, 2026 Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advan
2026-05-30Press releaseMay 30, 2026 Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combinati
2026-05-28Press releaseCogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Comb
2026-05-27Press releaseCogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
2026-05-12PresentationMay 2026 Corporate Presentation
2026-05-12Press releaseCogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
2026-05-05Press releaseCogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
2026-04-21Press releaseCogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST)
2026-04-01Press releaseRead More
2026-03-16Press releaseRead More
2026-02-28Press releaseRead More
2026-02-17Press releaseRead More
2026-02-10Press releaseRead More
2026-01-26Press releaseRead More
2026-01-20Press releaseRead More
2026-01-12Press releaseRead More
2026-01-06Press releaseRead More
2025-12-08PresentationPresentation
2025-11-10PresentationPresentation
2025-07-07PresentationTop-Line Results from SUMMIT Trial in NonAdvanced SM Patients
2023-12-04Press releaseRead More
2022-06-06Press releaseRead More

COGT overview · COGT earnings · COGT financials · COGT KPIs · COGT documents · COGT ownership · COGT peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.